A recently-developed testing method called Genomic Allergen Rapid Detection (GARD) could prove a valuable tool for the e-cig industry, claims a new study sponsored by Imperial Brands’ Fontem Ventures.
Celebrating our 10th anniversary – Unlock our special offer today
A recently-developed testing method called Genomic Allergen Rapid Detection (GARD) could prove a valuable tool for the e-cig industry, claims a new study sponsored by Imperial Brands’ Fontem Ventures.